triamterene has been researched along with Experimental Lung Inflammation in 1 studies
Triamterene: A pteridinetriamine compound that inhibits SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS.
triamterene : Pteridine substituted at positions 2, 4 and 7 with amino groups and at position 6 with a phenyl group. A sodium channel blocker, it is used as a diuretic in the treatment of hypertension and oedema.
Experimental Lung Inflammation: Inflammation of any part, segment or lobe, of the lung parenchyma.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zamotaev, IP | 1 |
| Kabakov, AI | 1 |
1 trial available for triamterene and Experimental Lung Inflammation
| Article | Year |
|---|---|
[Comparative evaluation of the effectiveness of diuretics].
Topics: Adolescent; Adult; Aged; Chronic Disease; Clinical Trials as Topic; Coronary Disease; Diuresis; Diur | 1976 |